Clinical Trials Logo

Clinical Trial Summary

The purpose is to explore the possible benefit of administration of Fisetin, (a senolytic agent) to improve the benefit of Platelet-Rich Plasma and losartan for treatment of femoroacetabular impingement and labral tear. We believe that giving Fisetin, a senolytic agent, will improve the benefit of PRP by eliminating senescent cells and senescence-associated secretory phenotype (SASP), known to exist in PRP. The main objectives of this study are to determine if pre- and post-operative administration of a senolytic agent will improve the beneficial effects of PRP when used in conjunction with surgical treatment of FAI and/or labral tear, to determine whether pre- and postoperative administration of Fisetin is associated with adverse events, and to determine if pre- and post-operative administration of Fisetin leads to a decrease in systemic senescence, serum SASP, and fibrotic markers. Patients suffering from femoroacetabular impingement and labral tear, who are planning to undergo hip arthroscopy combined with standard of care intra-operative PRP injection and post-operative losartan administration will be recruited from the clinical practice of the Principal Clinical Investigator or his designee at The Steadman Clinic (TSC).


Clinical Trial Description

This is a pilot, prospective, randomized, double-blind, placebo control clinical trial is proposed to evaluate the safety and efficacy of a senolytic agent (Fisetin) to improve the benefits of standard of care platelet rich plasma (PRP) injection and antifibrotic medication (Losartan) in patients undergoing hip arthroscopy for treatment of femoroacetabular impingement (FAI) and/or labral tear (LT). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05025956
Study type Interventional
Source Steadman Philippon Research Institute
Contact Suzanne L Page, JD
Phone 970-401-8770
Email [email protected]
Status Recruiting
Phase Phase 1/Phase 2
Start date September 2021
Completion date August 2024

See also
  Status Clinical Trial Phase
Completed NCT01623843 - Femoroacetabular Impingement RandomiSed Controlled Trial N/A
Completed NCT03669471 - Muscular and Functional Performance in FAIS Patients
Not yet recruiting NCT05031390 - the Horsens Aarhus FemoroAcetabular Impingement Syndrome Training Pilot Study N/A
Withdrawn NCT02674113 - Regional Anesthesia in Hip Arthroscopy N/A
Withdrawn NCT02260726 - Evaluation of Ultrasound for Detecting Hip Impingement N/A
Recruiting NCT03891563 - Prospective Evaluation of Sport Activity and the Development of Femoroacetabular Impingement in the Adolescent Hip
Recruiting NCT04069507 - Healthy Hip Study: Conservative Management for Pre-arthritic Hip Disorders
Terminated NCT03278353 - Fulfillment of Expectations for Patients With FAI Syndrome N/A
Terminated NCT03995290 - 3D Modeling to Improve Hip Arthroscopy Outcomes
Recruiting NCT01621360 - Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement N/A
Completed NCT04980209 - The Feasibility and Application of Intraoperative Ultrasound to Evaluate Femoral Head Shaping
Enrolling by invitation NCT04988659 - Analysis of Gene Expression in Femoroacetabular Impingement (FAI)
Recruiting NCT03494660 - SCP Hip Outcomes Study
Withdrawn NCT02706756 - Conservative Intervention of Femoroacetabular Impingement Syndrome N/A
Completed NCT02702661 - PRCT of FICB vs LAI for Hip Arthroscopy N/A
Completed NCT01814124 - Conservative Management of Femoroacetabular Impingement N/A
Completed NCT01993615 - A Physical Therapy Program Versus Surgery for Femoroacetabular Impingement: Randomized Clinical Trial N/A
Recruiting NCT04302077 - Patient Satisfaction With Virtual Post Operative Visits: Hip Arthroscopy N/A
Recruiting NCT03846817 - Diagnosis and Treatment of Patients With Femoroacetabular Impingement Syndrome N/A
Recruiting NCT04265222 - Cam Decompression Utilizing the Stryker Hip-Check Software Platform N/A